podophyllotoxin has been researched along with lissamine rhodamine b in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, B; Chen, H; Cheng, MS; He, CX; Lei, ZY; Li, M; Wang, J; Yang, N; Yu, PF | 1 |
| Bai, S; Bi, W; Cao, B; Chen, H; Wang, J; Wang, Y; Xie, W; Yu, PF; Zhang, J | 1 |
2 other study(ies) available for podophyllotoxin and lissamine rhodamine b
| Article | Year |
|---|---|
Design, synthesis and cytotoxicity of novel podophyllotoxin derivatives.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colorimetry; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Podophyllotoxin; Rhodamines; Tetrazolium Salts; Thiazoles; Tubulin | 2008 |
L1EPO, a novel podophyllotoxin derivative overcomes P-glycoprotein-mediated multidrug resistance in K562/A02 cell line.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Blotting, Western; Coloring Agents; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Humans; K562 Cells; KB Cells; Podophyllotoxin; Reverse Transcriptase Polymerase Chain Reaction; Rhodamines; RNA, Messenger | 2009 |